NFKB1 and cardiovascular disorder: Therefore, it is necessary to identify NFKB1 genotypes in the population at high risk of cardiovascular diseases, and for those with DD genotype aggressive clinical pharmacological and healthy lifestyle interventions should be implemented to reduce the occurrence of MACCEs.